Jacques Borger

4.6k total citations · 1 hit paper
62 papers, 3.6k citations indexed

About

Jacques Borger is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Jacques Borger has authored 62 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cancer Research, 26 papers in Pulmonary and Respiratory Medicine and 24 papers in Radiation. Recurrent topics in Jacques Borger's work include Breast Cancer Treatment Studies (38 papers), Advanced Radiotherapy Techniques (24 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Jacques Borger is often cited by papers focused on Breast Cancer Treatment Studies (38 papers), Advanced Radiotherapy Techniques (24 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Jacques Borger collaborates with scholars based in Netherlands, United States and France. Jacques Borger's co-authors include Harry Bartelink, Johannes L. Peterse, Coen Hurkmans, J.J. Jager, Alain Fourquet, Jean-Claude Horiot, Philip Poortmans, M. Piérart, Laurence Collette and H. Struikmans and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jacques Borger

59 papers receiving 3.5k citations

Hit Papers

Recurrence Rates after Treatment of Breast Cancer with St... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
    2001 693 citations Harry Bartelink, I. Barillot et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Borger Netherlands 29 2.2k 1.1k 1.1k 1.1k 1.0k 62 3.6k
Francisco Perera Canada 26 2.1k 0.9× 939 0.8× 951 0.9× 694 0.6× 1.2k 1.1× 53 3.2k
V Evans United Kingdom 3 2.9k 1.3× 1.3k 1.2× 855 0.8× 773 0.7× 1.4k 1.4× 5 3.8k
Birgitte Vrou Offersen Denmark 32 2.3k 1.0× 708 0.6× 1.0k 0.9× 901 0.8× 986 0.9× 125 3.3k
Csaba Polgár Hungary 30 3.0k 1.3× 1.6k 1.5× 1.7k 1.6× 707 0.7× 1.0k 1.0× 210 4.2k
Douglas W. Arthur United States 39 3.9k 1.8× 1.8k 1.6× 2.2k 2.0× 1.1k 1.0× 1.3k 1.2× 121 5.0k
Anthony Abner United States 23 2.7k 1.2× 1.6k 1.5× 460 0.4× 504 0.5× 1.4k 1.4× 48 3.7k
Claudia Sangalli Italy 33 1.6k 0.7× 1.1k 1.0× 539 0.5× 322 0.3× 1.4k 1.3× 101 3.4k
C. Gadeberg Denmark 12 2.8k 1.3× 1.5k 1.4× 592 0.5× 394 0.4× 1.4k 1.3× 26 3.8k
François Campana France 29 1.8k 0.8× 1.0k 0.9× 472 0.4× 306 0.3× 917 0.9× 58 2.4k
Rainer Souchon Germany 27 1.6k 0.7× 690 0.6× 535 0.5× 486 0.5× 1.1k 1.1× 98 3.4k

Countries citing papers authored by Jacques Borger

Since Specialization
Citations

This map shows the geographic impact of Jacques Borger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Borger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Borger more than expected).

Fields of papers citing papers by Jacques Borger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Borger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Borger. The network helps show where Jacques Borger may publish in the future.

Co-authorship network of co-authors of Jacques Borger

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Borger. A scholar is included among the top collaborators of Jacques Borger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Borger. Jacques Borger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reymen, Bart, Angela van Baardwijk, Rinus Wanders, et al.. (2014). Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR). Radiotherapy and Oncology. 110(3). 482–487. 19 indexed citations
2.
3.
Oberije, Cary, Georgi Nalbantov, André Dekker, et al.. (2014). A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making. Radiotherapy and Oncology. 112(1). 37–43. 75 indexed citations
4.
Reymen, Bart, Judith van Loon, Angela van Baardwijk, et al.. (2012). Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1319–1324. 34 indexed citations
5.
Baardwijk, Angela van, Bart Reymen, Rinus Wanders, et al.. (2011). Results of a phase II trial on individualized radiation dose-escalation based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 6(6).
6.
Steevens, Jessie, Dirk De Ruysscher, Anita A.M. Botterweck, et al.. (2011). Also elderly patients (75 years or older) with stage III non-small cell lung cancer (nsclc) have survival gains with radical treatment: a prospective population-based study. Journal of Thoracic Oncology. 6(6). 1 indexed citations
7.
Baardwijk, Angela van, S. Wanders, Liesbeth Boersma, et al.. (2010). Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 28(8). 1380–1386. 138 indexed citations
8.
Baardwijk, Angela van, Rinus Wanders, Bart Reymen, et al.. (2010). First Results of a Phase II Trial Investigating Individualized Dose-escalation Based on Normal Tissue Constraints in Concurrent Chemo-radiation for Locally Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00572325). International Journal of Radiation Oncology*Biology*Physics. 78(3). S108–S108. 3 indexed citations
9.
Aerts, Hugo J.W.L., Steven Petit, Judith van Loon, et al.. (2009). Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan. Radiotherapy and Oncology. 91(3). 386–392. 151 indexed citations
10.
Borger, Jacques, et al.. (2008). Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer. Radiotherapy and Oncology. 87(3). 350–356. 7 indexed citations
11.
Loon, Judith van, Geert Bosmans, Rinus Wanders, et al.. (2008). 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study. Radiotherapy and Oncology. 87(1). 49–54. 59 indexed citations
12.
Borger, Jacques, Maartje J. Hooning, Liesbeth Boersma, et al.. (2007). Cardiotoxic Effects of Tangential Breast Irradiation in Early Breast Cancer Patients: The Role of Irradiated Heart Volume. International Journal of Radiation Oncology*Biology*Physics. 69(4). 1131–1138. 106 indexed citations
13.
Pieters, Bradley R., Augustinus A. M. Hart, Nicola S. Russell, et al.. (2003). A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy. Radiotherapy and Oncology. 67(2). 159–164. 8 indexed citations
14.
Bartelink, H., P Poortmans, Jacques Borger, et al.. (2002). Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(9). 416–423. 1 indexed citations
15.
Bijker, Nina, Emiel J. Rutgers, Johannes L. Peterse, et al.. (1999). Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Cancer. 85(8). 1773–1781. 2 indexed citations
16.
Bijker, Nina, Emiel J. Rutgers, Johannes L. Peterse, et al.. (1999). Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Cancer. 85(8). 1773–1781. 20 indexed citations
17.
Russell, Nicola S., Annette Grummels, A.A.M. Hart, et al.. (1998). Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. International Journal of Radiation Biology. 73(6). 661–670. 73 indexed citations
18.
Tienhoven, Geertjan van, Jacques Borger, A. A. M. Hart, et al.. (1995). The prognostic significance of the axillary apex biopsy in clinically operable breast cancer. European Journal of Cancer. 31(12). 1965–1968. 14 indexed citations
19.
Borger, Jacques, Geertjan van Tienhoven, Augustinus A. M. Hart, et al.. (1992). Primary radiotherapy of breast cancer: Treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy. Radiotherapy and Oncology. 25(1). 1–11. 26 indexed citations
20.
Borger, Jacques. (1991). The impact of surgical and pathological findings on radiotherapy of early breast cancer. Radiotherapy and Oncology. 22(4). 230–236. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Perera Breakdown of academic impact, for papers by V Evans Breakdown of academic impact, for papers by Birgitte Vrou Offersen Breakdown of academic impact, for papers by Csaba Polgár Breakdown of academic impact, for papers by Douglas W. Arthur Breakdown of academic impact, for papers by Anthony Abner Breakdown of academic impact, for papers by Claudia Sangalli Breakdown of academic impact, for papers by C. Gadeberg Breakdown of academic impact, for papers by François Campana Breakdown of academic impact, for papers by Rainer Souchon
Rankless by CCL
2026